Holding(s) in Company

Summary by AI BETAClose X

Spreadex LTD has notified CRISM Therapeutics Corporation that its total voting rights have decreased to 2.941200% as of November 19, 2025, down from a previous holding of 3.128900%. This change is due to an acquisition or disposal of voting rights, with Spreadex LTD now holding 1,175,000 direct voting rights attached to shares and 374 voting rights through financial instruments, totaling 1,175,374 voting rights.

Disclaimer*

UK 100

Latest directors dealings